Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Common Stock | Options Exercise | $543K | +21.2K | +32.03% | $25.60 | 87.4K | Feb 26, 2022 | Direct | F1 |
transaction | PFE | Common Stock | Tax liability | -$220K | -4.62K | -5.29% | $47.72 | 82.7K | Feb 26, 2022 | Direct | F2, F3 |
transaction | PFE | Common Stock | Tax liability | -$501K | -9.9K | -11.96% | $50.64 | 72.8K | Feb 26, 2022 | Direct | F4, F5 |
transaction | PFE | Common Stock | Tax liability | -$84.3K | -1.8K | -2.46% | $46.94 | 71.1K | Feb 28, 2022 | Direct | F6 |
holding | PFE | Common Stock | 2.92K | Feb 26, 2022 | By Rule 16b-3 Plan |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -21.2K | -100% | $0.00* | 0 | Feb 26, 2022 | Common Stock | 21.2K | $25.60 | Direct |
Id | Content |
---|---|
F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
F3 | Price is the closing price of Pfizer common stock on February 25, 2022. |
F4 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
F5 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
F6 | The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). |